MED · Medifast Inc
$11.44
-0.04 (-0.35%)
At close · Aug 14
Market Cap
$127.91M
Shares
11.18M
Medifast Inc Earnings Call Transcripts
Every quarterly earnings call for Medifast Inc (MED) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼5.6%
$390.40M
$36.16M
'22 Q3
22-11-03
▼10.7%
$337.25M
$26.52M
'22 Q4
23-02-21
▼16.4%
$348.98M
$39.97M
'23 Q1
23-05-01
▼34.7%
$296.19M
$30.28M
'23 Q2
23-08-07
▼39.6%
$235.87M
$23.13M
'23 Q3
23-11-06
▼43.4%
$191.01M
$6.04M
'23 Q4
24-02-20
▼49.9%
$174.74M
$8.32M
'24 Q1
24-04-29
▼43.1%
$168.56M
−$8.15M
'24 Q2
24-08-05
▼40.6%
$140.16M
$1.13M
'24 Q3
24-11-04
▼37.7%
$119.00M
$800,000
'24 Q4
25-02-18
▼33.8%
$115.73M
−$772,000
'25 Q1
25-04-28
▼37.4%
$105.56M
$2.48M
'25 Q2
25-08-04
▼36.2%
$89.41M
−$2.26M
'25 Q3
25-11-03
▼36.9%
$75.10M
−$18.12M
'25 Q4
26-02-17
▼34.3%
$76.04M
−$2.12M
'26 Q1
26-05-04
LATEST
▼27.6%
$76.38M
−$3.10M
'26 Q2
26-08-03
Earnings call
FY26 · Q2
2026-08-03
Medifast Second Quarter 2026 Earnings Webcast
Positive tone
Trilovie Brand Launch & Product Transition
Metabolic Health Positioning & GLP-1
Revenue Stabilization
Revenue
$76.38M
▼ 27.6% YoY Diluted EPS
$-0.28
▼ 227.3% YoY Gross margin
69.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-04
Medifast Inc Q1 FY2026 Earnings Call
Positive tone
Metabolic health repositioning
Coach productivity and field execution
Body composition and clinical outcomes
Revenue
$76.04M
▼ 34.3% YoY Diluted EPS
$-0.19
Gross margin
68.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Medifast Inc Q4 FY2025 Earnings Call
Positive tone
Metabolic Health Repositioning
Leadership Transition
Coach Productivity Improvement
Revenue
$75.10M*
▼ 36.9% YoY Gross margin
69.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Medifast Inc Q3 FY2025 Earnings Call
Positive tone
Coach network and coaching
Metabolic health positioning
EDGE leadership program
Revenue
$89.41M
▼ 36.2% YoY Diluted EPS
$-0.21
▼ 310% YoY Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-04
Medifast Inc Q2 FY2025 Earnings Call
Positive tone
GLP-1 positioning and opportunity
Clinical research and metabolic health science
Coach productivity and growth initiatives
Revenue
$105.56M
▼ 37.4% YoY Diluted EPS
$0.22
Gross margin
72.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-28
Medifast Inc Q1 FY2025 Earnings Call
Positive tone
GLP-1 drugs impact and opportunity
Coach-led business model and productivity
Q1 financial results
Revenue
$115.73M
▼ 33.8% YoY Diluted EPS
$-0.07
▼ 109.2% YoY Gross margin
72.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-18
Medifast Inc Q4 FY2024 Earnings Call
Balanced tone
GLP-1 market adaptation
Coach productivity trends
Cash flow and balance sheet
Revenue
$119.00M*
▼ 37.7% YoY Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-04
Medifast Inc Q3 FY2024 Earnings Call
Cautious tone
GLP-1 market transformation
Coach network and training
LifeMD partnership
Revenue
$140.16M
▼ 40.6% YoY Diluted EPS
$0.10
▼ 95.3% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Medifast Inc Q2 FY2024 Earnings Call
Cautious tone
GLP-1 market opportunity and pivot
Balance sheet and capital allocation
Company-led advertising and customer acquisition
Revenue
$168.56M
▼ 43.1% YoY Diluted EPS
$-0.75
▼ 127.1% YoY Gross margin
73.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-29
Medifast Inc Q1 FY2024 Earnings Call
Positive tone
LifeMD collaboration and integrated solution
OPTAVIA coaches and community support
Financial results and quarterly performance
Revenue
$174.74M
▼ 49.9% YoY Diluted EPS
$0.76
▼ 79.3% YoY Gross margin
72.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Medifast Inc Q4 FY2023 Earnings Call
Positive tone
Q1 EPS guidance range / execution uncertainty
GLP-1 / LifeMD collaboration
Fuel for the Future cost program
Revenue
$191.01M*
▼ 43.4% YoY Gross margin
74.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
Medifast Inc Q3 FY2023 Earnings Call
Revenue
$235.87M
▼ 39.6% YoY Diluted EPS
$2.12
▼ 35.2% YoY Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
Medifast Inc Q2 FY2023 Earnings Call
Revenue
$296.19M
▼ 34.7% YoY Diluted EPS
$2.77
▼ 19% YoY Gross margin
71.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
Medifast Inc Q1 FY2023 Earnings Call
Revenue
$348.98M
▼ 16.4% YoY Diluted EPS
$3.67
▲ 2.2% YoY Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Medifast Inc Q4 FY2022 Earnings Call
Revenue
$337.25M*
▼ 10.7% YoY Gross margin
69.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Medifast Inc Q3 FY2022 Earnings Call
Revenue
$390.40M
▼ 5.6% YoY Diluted EPS
$3.27
▼ 8.1% YoY Gross margin
72.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Medifast Inc Q2 FY2022 Earnings Call
Revenue
$453.33M
▲ 15% YoY Diluted EPS
$3.42
▼ 13.6% YoY Gross margin
71.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
Medifast Inc Q1 FY2022 Earnings Call
Revenue
$417.60M
▲ 22.6% YoY Diluted EPS
$3.59
▲ 3.8% YoY Gross margin
72.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
Medifast Inc Q4 FY2021 Earnings Call
Revenue
$377.83M*
▲ 42.6% YoY Gross margin
73.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Medifast Inc Q3 FY2021 Earnings Call
Revenue
$413.39M
▲ 52.3% YoY Diluted EPS
$3.56
▲ 22.3% YoY Gross margin
74.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Medifast Inc Q2 FY2021 Earnings Call
Revenue
$394.19M
▲ 79.2% YoY Diluted EPS
$3.96
▲ 112.9% YoY Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Medifast Inc Q1 FY2021 Earnings Call
Revenue
$340.67M
▲ 90.9% YoY Diluted EPS
$3.46
▲ 121.8% YoY Gross margin
73.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Medifast Inc Q4 FY2020 Earnings Call
Revenue
$264.91M
▲ 55.3% YoY Diluted EPS
$2.36
▲ 42.2% YoY Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-02
Medifast Inc Q3 FY2020 Earnings Call
Revenue
$271.47M
▲ 42.8% YoY Diluted EPS
$2.91
▲ 120.5% YoY Gross margin
75.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Medifast Inc Q2 FY2020 Earnings Call
Revenue
$220.00M
▲ 17.6% YoY Diluted EPS
$1.86
▲ 6.3% YoY Gross margin
72.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-05
Medifast Inc Q1 FY2020 Earnings Call
Revenue
$178.46M
▲ 7.6% YoY Diluted EPS
$1.56
▼ 8.2% YoY Gross margin
75.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-26
Medifast Inc Q4 FY2019 Earnings Call
Revenue
$170.63M
▲ 17% YoY Diluted EPS
$1.66
▲ 27.7% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
910329
CUSIP
58470H101
13F (30d)
109 filings
107 filers
Visit website
Investor relations